Notably, 24 of the patients in the study were found at analysis not to have fulfilled the Sapporo criteria for persistent APLA positivity, having either had only one isolated positive result, or aCL and/or aβ2GP1 at low-titer only, though all patients were considered to have APS by the treating clinician. This evidence concerns the gene ACLY and autoimmune polyendocrinopathy.